These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25973304)

  • 1. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
    Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
    Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
    Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
    He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
    Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
    Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
    Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
    Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
    Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
    Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
    Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
    Xu J; Qian J; Zhang W; Chen E; Zhang G; Cao G; Wang F; Shen X; Zhou W; Song Z
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
    Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
    J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling.
    Yu Y; Yan W; Liu X; Jia Y; Cao B; Yu Y; Lv Y; Brock MV; Herman JG; Licchesi J; Yang Y; Guo M
    Am J Cancer Res; 2014; 4(6):710-24. PubMed ID: 25520862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
    Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
    Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.
    Jia Y; Cao B; Yang Y; Linghu E; Zhan Q; Lu Y; Yu Y; Herman JG; Guo M
    Oncotarget; 2015 Oct; 6(32):33470-85. PubMed ID: 26396173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis.
    Zhang B; Guo DD; Zheng JY; Wu YA
    Eur J Cancer Prev; 2018 Jan; 27(1):20-26. PubMed ID: 29084019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
    Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.